MiR-506-3p suppresses papillary thyroid cancer cells tumorigenesis by targeting YAP1

被引:30
作者
Chen, Lei [1 ,2 ]
Wang, Xuehui [1 ,2 ]
Ji, Changle [2 ]
Hu, Jiashu [2 ]
Fang, Lin [1 ,2 ]
机构
[1] Nanjing Med Univ, Shanghai Peoples Hosp 10, Clin Med Coll, Nanjing 211166, Peoples R China
[2] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Thyroid & Breast Surg, Shanghai 200072, Peoples R China
关键词
Papillary thyroid cancer; miR-506-3p; YAP1; Proliferation;
D O I
10.1016/j.prp.2020.153231
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Thyroid cancer (TC) is the most common endocrine cancer in the world and about 80-85 % patients with TC belong to papillary thyroid cancer (PTC). MicroRNAs(MiRNAs) are a class of non-coding RNAs that can negatively modulate gene expression post-transcriptionally and play a role in tumorigenesis and development. The purpose of this study was to explore the biological function of miR-506-3p in PTC. We found that miR-506-3p suppressed cell proliferation disrupted the cell cycle of PTC cells in vitro. Mechanistically, we found that YAP1 was a direct target gene of miR-506-3p. Western Blot and RT-qPCR results indicated that miR-506-3p could down-regulate the expression of YAP1 at both mRNA and protein levels. Furthermore, miR-506-3p could also suppress the expression of CDK2/Cyclin E1 compound which could be affected by YAP1 gene. Therefore miR-506-3p might have proliferation-suppressive function in PTC by inhibiting YAP1 expression and regulating YAP1-CDK2/Cy clin E1 cell cycle pathway.
引用
收藏
页数:8
相关论文
共 35 条
[1]   YAP1 increases organ size and expands undifferentiated progenitor cells [J].
Camargo, Fernando D. ;
Gokhale, Sumita ;
Johnnidis, Jonathan B. ;
Fu, Dongdong ;
Bell, George W. ;
Jaenisch, Rudolf ;
Brummelkamp, Thijn R. .
CURRENT BIOLOGY, 2007, 17 (23) :2054-2060
[2]   Thyroid Cancer [J].
Carling, Tobias ;
Udelsman, Robert .
ANNUAL REVIEW OF MEDICINE, VOL 65, 2014, 65 :125-137
[3]   Expression of YAP1 in aggressive thyroid cancer [J].
Celano, Marilena ;
Mignogna, Chiara ;
Rosignolo, Francesca ;
Sponziello, Marialuisa ;
Iannone, Michelangelo ;
Lepore, Saverio Massimo ;
Lombardo, Giovanni Enrico ;
Maggisano, Valentina ;
Verrienti, Antonella ;
Bulotta, Stefania ;
Durante, Cosimo ;
Di Loreto, Carla ;
Damante, Giuseppe ;
Russo, Diego .
ENDOCRINE, 2018, 59 (01) :209-212
[4]   miR-506-3p alleviates uncontrolled osteoclastogenesis via repression of RANKL/NFATc1 signaling pathway [J].
Dinesh, Palani ;
Kalaiselvan, Sowmiya ;
Sujitha, Sali ;
Rasool, Mahaboobkhan .
JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (12) :9497-9509
[5]   Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma [J].
Gao, Xujie ;
Wu, Yupeng ;
Yu, Wenwen ;
Li, Hui .
ONCOTARGET, 2016, 7 (49) :81670-81679
[6]   Nomograms predicting disease-specific regional recurrence and distant recurrence of papillary thyroid carcinoma following partial or total thyroidectomy [J].
Ge, Ming-Hua ;
Cao, Jun ;
Wang, Jin-Yu ;
Huang, Yu-Qing ;
Lan, Xia-Bin ;
Yu, Bin ;
Wen, Qing-Liang ;
Cai, Xiu-Jun .
MEDICINE, 2017, 96 (30)
[7]  
Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022
[8]   YAP and TAZ: a nexus for Hippo signaling and beyond [J].
Hansen, Carsten Gram ;
Moroishi, Toshiro ;
Guan, Kun-Liang .
TRENDS IN CELL BIOLOGY, 2015, 25 (09) :499-513
[9]   MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer-cells via targeting CKS2 [J].
Hua, Kaiyao ;
Jin, Jiali ;
Zhang, Huiwen ;
Zhao, Bingkun ;
Wu, Chenyang ;
Xu, Hui ;
Fang, Lin .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (04) :1531-1540
[10]   miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2 [J].
Hua, Kaiyao ;
Jin, Jiali ;
Zhao, Junyong ;
Song, Jialu ;
Song, Hongming ;
Li, Dengfeng ;
Maskey, Niraj ;
Zhao, Bingkun ;
Wu, Chenyang ;
Xu, Hui ;
Fang, Lin .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (05) :1997-2006